SLDB (STOCKS)
Solid Biosciences Inc. Common Stock
$7.360000
+0.220000 (+3.08%)
Prev close: $7.140000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Alexander Gery Cumbo
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $725.57M
- Employees
- 100
- P/E (TTM)
- -3.67
- P/B (TTM)
- 1.88
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $4.68M |
| Operating Expenses | $196.46M |
| Depreciation and Amortization | $1.62M |
| Research and Development | $155.55M |
| Other Operating Expenses | $40.05M |
| Operating Income/Loss | -$196.46M |
| Income/Loss From Continuing Operations After Tax | -$191.65M |
| Income/Loss From Continuing Operations Before Tax | -$191.65M |
| Net Income/Loss | -$191.78M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$191.78M |
| Net Income/Loss Available To Common Stockholders, Basic | -$191.78M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.95 |
| Diluted Earnings Per Share | -$1.95 |
| Basic Average Shares | 300,804,836 |
| Diluted Average Shares | 300,804,836 |
| Assets | $422.89M |
| Current Assets | $396.79M |
| Cash | $380.70M |
| Other Current Assets | $16.09M |
| Noncurrent Assets | $26.11M |
| Fixed Assets | $3.91M |
| Other Non-current Assets | $22.19M |
| Liabilities | $48.76M |
| Current Liabilities | $30.28M |
| Accounts Payable | $5.56M |
| Other Current Liabilities | $24.72M |
| Noncurrent Liabilities | $18.48M |
| Equity | $374.13M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $374.13M |
| Liabilities And Equity | $422.89M |
| Net Cash Flow From Operating Activities | -$171.67M |
| Net Cash Flow From Operating Activities, Continuing | -$171.67M |
| Net Cash Flow From Investing Activities | $13.77M |
| Net Cash Flow From Investing Activities, Continuing | $13.77M |
| Net Cash Flow From Financing Activities | $243.75M |
| Net Cash Flow From Financing Activities, Continuing | $243.75M |
| Net Cash Flow | $85.84M |
| Net Cash Flow, Continuing | $85.84M |
| Comprehensive Income/Loss | -$191.80M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$191.76M |
| Other Comprehensive Income/Loss | $25.00K |